Insider Transactions Reported by 13 Insiders of Protagonist Therapeutics, Inc

Symbol
PTGX on Nasdaq
Location
Newark, CA

Insiders trading volume in the past year

Protagonist Therapeutics, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
DINESH V. PH D. PATEL President and CEO, Director $47,793,070 -$10,354,767 -18% 23 Jan 2026
ARTURO MOLINA MD Chief Medical Officer $6,897,430 -$5,746,167 -45% 23 Jan 2026
Asif Ali Chief Financial Officer $5,015,004 -$6,092,705 -55% 27 Jan 2026
David Y. Liu Chief R&D Strategy Officer $4,127,742 16 Nov 2022
Suneel Gupta Chief Development Officer $3,254,660 25 Nov 2024
Bryan Giraudo Director $2,255,549 02 Jan 2026
Sarah A. O'Dowd Director $683,433 02 Jan 2026
William D. Waddill Director $654,796 -$3,364,080 -84% 06 Feb 2026
Lewis T. Williams Director $644,936 -$1,483,560 -70% 17 Feb 2026
Donald A. Kalkofen Chief Financial Officer $456,172 15 Feb 2022
HAROLD E. SELICK Director $256,157 09 Jan 2026
Sarah B. Noonberg Director 16 Jan 2023
Daniel N. Swisher JR Director 26 Oct 2023

Recent Insider Transactions by Companies or Individuals for Protagonist Therapeutics, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.